Location of functioning metastases from differentiated thyroid carcinoma by simultaneous double isotope acquisition of I-131 whole body scan and bone scan

Journal of Endocrinological Investigation

Volumn 27, Issue 9, 2004, Pages 866-869

  Ceccarelli, Claudia ^a   Bianchi, F ^a   Trippi, D ^a   Brozzi, F ^a   Di Martino, F ^a   Santini, P ^a   Elisei, R ^a   Pinchera, A ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Bone metastases; Double isotope acquisition; Location of metastases; Metastases from differentiated thyroid cancer; Therapy with I 131

Indexed keywords

IODINE 131; OXIDRONATE TECHNETIUM TC 99M; THYROTROPIN;

ADULT; ARTICLE; BONE ATROPHY; BONE METASTASIS; BONE SCINTISCANNING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; HUMAN; ILIAC BONE; LUMBAR VERTEBRA; LUNG SCINTISCANNING; MALE; SCINTILLATION CAMERA; THYROID CARCINOMA; THYROIDECTOMY; THYROTROPIN BLOOD LEVEL; WHOLE BODY SCINTISCANNING;

EID: 14544281183     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03346282     Document Type: Article

References (11)

1. Sutton RT, Reading CC, Charboneau JW, James EM, Grant CS, Hay ID. US-guided biopsy of neck masses in postoperative management of patients with thyroid cancer. Radiology 1988, 168: 769-72.
2. Lorenzen J, Beese M, Mester J, Brumma K, Beyer W, Clausen M. Chest X ray: routine indication in the follow-up of differentiated thyroid cancer? Nuklearmedizin 1998, 37: 208-12.
3. Perault C, Schvartz C, Wampach H, Liehn JC, Delisle MJ. Thoracic and abdominal SPECT-CT image fusion without external markers in endocrine carcinomas. The Group of Thyroid Tumoral Pathology of Champagne-Ardenne. J Nucl Med 1997, 38: 1234-42.
4. Freudenberg LS, Antoch G, Gorges R, et al. Combined PET/CT with iodine-124 in diagnosis of spread metastatic thyroid carcinoma: a case report. Eur Radiol 2003, 13 (Suppl 4): L19-23.
5. Petrich T, Widjaja A, Musholt TJ, et al. Outcome after radioiodine therapy in 107 patients with differentiated thyroid carcinoma and initial bone metastases: side effects and influence of age. Eur J Nucl Med 2001, 28: 203-8.
6. Marcocci C, Pacini F, Elisei R, et al. Clinical and biological behavior of bone metastases from differentiated thyroid carcinoma. Surgery 1989, 106 (6): 960-6.
7. Pacini F, Cetani F, Miccoli P, et al. Outcome of 309 patients with metastatic thyroid carcinoma. World J Surg 1994, 18: 600-4.
8. Pacini F, Molinaro E, Castagna MG, et al. Ablation of thyroid residues with 30 mCi (131)I: a comparison in thyroid cancer patients prepared with recombinant human TSH or thyroid hormone withdrawal. J Clin Endocrinol Metab 2002, 87: 4059-62.
9. Pacini F, Molinaro E, Castagna MG, et al. Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma. J Clin Endocrinol Metab 2003, 88: 3668-73.
10. Mertens IJ, De Klerk JM, Zelissen PM, et al. Undetectable serum thyroglobulin in a patient with metastatic follicular cancer. Clin Nucl Med 1999, 24: 346-9.
11. Westbury C, Vini L, Fisher C, Harmer C. Recurrent differentiated thyroid cancer without elevation of serum thyroglobulin. Thyroid 2000, 10: 171-6.